EI
PFE icon

Ethic Inc’s Pfizer PFE Stock Holding History

Ethic Inc’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$21.2M Buy
882,175
+81,670
+10% +$2.14M 0.26% 54
2026
Q1 		$22.5M Buy
800,505
+81,567
+11% +$2.17M 0.35% 43
2025
Q4 		$17.9M Buy
718,938
+1,977
+0.3% +$49.9K 0.28% 60
2025
Q3 		$18.3M Sell
716,961
-47,368
-6% -$1.17M 0.3% 56
2025
Q2 		$18.5M Buy
764,329
+120,814
+19% +$2.82M 0.33% 46
2025
Q1 		$15.8M Buy
643,515
+194,041
+43% +$5.08M 0.32% 52
2024
Q4 		$11.9M Buy
449,474
+129,381
+40% +$3.51M 0.24% 78
2024
Q3 		$8.88M Sell
320,093
-49,341
-13% -$1.44M 0.22% 91
2024
Q2 		$10.3M Buy
369,434
+49,341
+15% +$1.36M 0.24% 78
2024
Q1 		$8.88M Sell
320,093
-64,200
-17% -$1.78M 0.22% 91
2023
Q4 		$11.1M Sell
384,293
-11,740
-3% -$355K 0.33% 54
2023
Q3 		$13.1M Buy
396,033
+34,696
+10% +$1.23M 0.46% 29
2023
Q2 		$13.3M Buy
361,337
+31,314
+9% +$1.22M 0.49% 31
2023
Q1 		$13.5M Buy
330,023
+115,015
+53% +$4.97M 0.55% 23
2022
Q4 		$11M Buy
215,008
+94,214
+78% +$4.52M 0.6% 22
2022
Q3 		$5.29M Buy
120,794
+41,481
+52% +$2.02M 0.36% 58
2022
Q2 		$4.16M Buy
79,313
+41,221
+108% +$2.1M 0.29% 82
2022
Q1 		$1.97M Buy
38,092
+18,498
+94% +$960K 0.14% 197
2021
Q4 		$1.16M Sell
19,594
-2,010
-9% -$99.6K 0.09% 257
2021
Q3 		$929K Buy
21,604
+2,527
+13% +$112K 0.1% 244
2021
Q2 		$747K Buy
19,077
+811
+4% +$31.5K 0.09% 266
2021
Q1 		$662K Sell
18,266
-1,763
-9% -$62.6K 0.12% 225
2020
Q4 		$737K Sell
20,029
-235
-1% -$8.62K 0.19% 129
2020
Q3 		$706K Buy
20,264
+11,879
+142% +$416K 0.27% 98
2020
Q2 		$260K Buy
+8,385
New +$285K 0.15% 196
2020
Q1 		– Sell
-8,293
Closed -$308K – 230
2019
Q4 		$308K Buy
+8,293
New +$295K 0.23% 150

Other funds holding PFE

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
SLAM
Swiss Life Asset Management Zurich $24.1B AUM 38.82% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
CWP
Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Retirement Systems of Alabama
Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return

Ethic Inc's PFE Position: Q2 2026 in Review

Ethic Inc increased its Pfizer (PFE) stake by 10% in Q2 2026, buying an estimated $2.14M and bringing the position to 882,175 shares worth $21.2M. The position accounts for 0.26% of the portfolio, ranked #54.

Ethic Inc first reported a position in PFE in Q4 2019 and has held it in 26 quarters since. The position peaked at $22.5M in Q1 2026. 1,218 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Ethic Inc held 882,175 shares of Pfizer worth $21.2M as of Q2 2026.
  • Ethic Inc bought 81,670 Pfizer shares in Q2 2026, an estimated $2.14M.
  • Pfizer made up 0.26% of Ethic Inc's portfolio in Q2 2026, its #54 holding.
  • Ethic Inc first reported a position in Pfizer in Q4 2019 and has held it in 26 quarters since.
  • Ethic Inc's Pfizer position peaked at $22.5M in Q1 2026.
  • 1,218 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Ethic Inc's 13F filing for Q2 2026, filed 29 Jul 2026.